Hsiang-Ling Chen

Title: Hsiang-Ling Chen: Innovator in Lactic Acid Bacteria Research

Introduction

Hsiang-Ling Chen is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of microbiology, particularly in the development of novel strains of lactic acid bacteria. His work aims to address critical health issues, showcasing his dedication to innovation and research.

Latest Patents

Hsiang-Ling Chen holds a patent for "Strains of lactic acid bacteria for preventing necrotizing enterocolitis." This invention relates to unique strains of lactic acid bacteria, specifically subsp. PM-A0087, deposited as NRRL accession number B-50523, PM-A0101, deposited as NRRL accession number B-50525, and PM-A0218, deposited as NRRL accession number B-50524. This patent highlights his commitment to advancing health solutions through scientific research.

Career Highlights

Chen is associated with Promd Biotech Co., Ltd., where he continues to innovate and develop new biotechnological solutions. His work at the company emphasizes the importance of research in creating effective health interventions.

Collaborations

Hsiang-Ling Chen collaborates with esteemed colleagues such as Wei-Chih Su and Kuang-Chih Lee. These partnerships enhance the research and development efforts within the field of biotechnology.

Conclusion

Hsiang-Ling Chen's contributions to the field of lactic acid bacteria research exemplify the impact of innovation in health sciences. His patent and ongoing work at Promd Biotech Co., Ltd. reflect his commitment to improving health outcomes through scientific advancements.